MANAGEMENT3

  • Mammalian target of rapamycin (mTOR) inhibitors can stabilize or slow decline in pulmonary function in patients who have progressive disease, with FEV1 <70%
  • Lung transplantation

See also

Test your Knowledge
Test your knowledge

Take the test

Lung X-Ray Example
Rad Rounds Mobile App

Download the app

Interstitial lung disease in systemic sclerosis with a focus on chest CT

Media Library

See Media